≡ Menu

Daiichi Sankyo to buy 51% in Ranbaxy

Japan’s second-largest pharmaceutical company Daiichi Sankyo buys up to 51 per cent stake in Indian Ranbaxy Laboratories at Rs 737 a share.

{ 0 comments… add one }

Leave a Comment